| Involvement of O-GlcNAcylation in the skeletal muscle physiology and physiopathology: Focus on muscle metabolism M Lambert, B Bastide, C Cieniewski-Bernard Frontiers in endocrinology 9, 578, 2018 | 35 | 2018 |
| O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins B Deracinois, L Camoin, M Lambert, JB Boyer, E Dupont, B Bastide, ... Journal of proteomics 186, 83-97, 2018 | 28 | 2018 |
| O-GlcNAcylation is a key modulator of skeletal muscle sarcomeric morphometry associated to modulation of protein–protein interactions M Lambert, E Richard, S Duban-Deweer, F Krzewinski, B Deracinois, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (9), 2017-2030, 2016 | 18 | 2016 |
| O-GlcNAcylation, contractile protein modifications and calcium affinity in skeletal muscle C Cieniewski-Bernard, M Lambert, E Dupont, V Montel, L Stevens, ... Frontiers in physiology 5, 421, 2014 | 18 | 2014 |
| PDE10A inhibition reduces the manifestation of pathology in DMD Zebrafish and represses the genetic modifier PITPNA MR Lambert, JM Spinazzola, JJ Widrick, A Pakula, JR Conner, JE Chin, ... Molecular Therapy 29 (3), 1086-1101, 2021 | 11 | 2021 |
| O‐GlcNAcylation as a regulator of the functional and structural properties of the sarcomere in skeletal muscle: An update review M Lambert, C Claeyssen, B Bastide, C Cieniewski‐Bernard Acta Physiologica 228 (1), e13301, 2020 | 11 | 2020 |
| Multiplexed detection of O-GlcNAcome, phosphoproteome, and whole proteome within the same gel C Cieniewski-Bernard, E Dupont, B Deracinois, M Lambert, B Bastide Frontiers in endocrinology 5, 184, 2014 | 7 | 2014 |
| Effect of serotonin modulation on dystrophin-deficient zebrafish JM Spinazzola, MR Lambert, DE Gibbs, JR Conner, GL Krikorian, ... Biology open 9 (8), bio053363, 2020 | 5 | 2020 |
| Optimizing assays of zebrafish larvae swimming performance for drug discovery JJ Widrick, MR Lambert, LM Kunkel, AH Beggs Expert Opinion on Drug Discovery, 1-13, 2023 | 2 | 2023 |
| Tropomyosin 3 (TPM3) function in skeletal muscle and in myopathy MR Lambert, E Gussoni Skeletal Muscle 13 (1), 18, 2023 | | 2023 |
| Jagged1 Ameliorates Dystrophic Phenotypes in Mouse Model of Duchenne Muscular Dystrophy YT Zhang, MR Lambert, JJ Widrick, JR Conner, JM Spinazzola, ... MOLECULAR THERAPY 30 (4), 501-502, 2022 | | 2022 |
| PRE-CLINICAL DEVELOPMENTS IN NEUROMUSCULAR DISORDERS: O. 13 Overexpression of JAG1 a therapeutic modifier for Duchenne muscular dystrophy Y Zhang, M Lambert, J Widrick, J Conner, J Spinazzola, L Kunkel Neuromuscular Disorders 31, S161, 2021 | | 2021 |
| DMD–ANIMAL MODELS: EP. 95 Downregulation of the genetic modifier PITPNA as means of therapy in Duchenne muscular dystrophy M Lambert, Y Zhang, J Spinazzola, J Widrick, J Conner, L Kunkel Neuromuscular Disorders 31, S78, 2021 | | 2021 |
| Overexpression of JAG1 a Disease Modifier for Duchenne Muscular Dystrophy Therapy YT Zhang, MR Lambert, JJ Widrick, JR Conner, JM Spinazzola, ... MOLECULAR THERAPY 29 (4), 294-295, 2021 | | 2021 |
| Caractérisation du rôle de la O-N-acétyl-glucosaminylation dans la structuration sarcomérique du muscle squelettique et de son implication dans certaines pathologies musculaires M Lambert Université de Lille, 2016 | | 2016 |
